close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

0.2492 +0.0144 (+6.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vistagen Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the 2025 Anxiety and Depression Association Conference
From Vistagen
Via Business Wire
News headline image
Vistagen to Participate in Stifel 2025 Virtual CNS Forum
From Vistagen
Via Business Wire
News headline image
Earnings Scheduled For February 13, 2025 ↗
 
Via Benzinga
News headline image
Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference
From Vistagen
Via Business Wire
News headline image
Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update
From Vistagen
Via Business Wire
News headline image
Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain
From Vistagen
Via Business Wire
News headline image
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia
From Vistagen
Via Business Wire
News headline image
Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the Stifel 2024 Healthcare Conference
From Vistagen
Via Business Wire
News headline image
Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
From Vistagen
Via Business Wire
News headline image
Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024
From Vistagen
Via Business Wire
TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day
Via Investor Brand Network
News headline image
Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day
From Vistagen
Via Business Wire
News headline image
Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
From Vistagen
Via Business Wire
BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2025 Financial, Corporate Report
Via Investor Brand Network
News headline image
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025 ↗
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. 
Via InvestorPlace
News headline image
Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update
From Vistagen
Via Business Wire
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q1 2025 Results, Conference Call
Via Investor Brand Network
News headline image
Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024
From Vistagen
Via Business Wire
News headline image
3 Stocks Under $15 That Could Make You a Millionaire ↗
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying. 
Via InvestorPlace
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio
Via Investor Brand Network
Topics Intellectual Property
News headline image
Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine
From Vistagen
Via Business Wire
InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Receives Mental Health America’s Highest Honor
Via Investor Brand Network
News headline image
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
From Vistagen
Via Business Wire
TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2024 Financial Report, Corporate Update
Via Investor Brand Network
News headline image
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024 ↗
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. 
Via InvestorPlace
News headline image
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
From Vistagen
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.